試す 金 - 無料
There's crushing news for people who want to live long
Mint Chennai
|April 21, 2025
A wonder drug that a wealthy longevity seeker was testing on himself may have turned out to be a dud
A few days ago, Bryan Johnson, a centi-millionaire who has spent millions on reversing ageing—especially his own—posted some bad news for humanity on his YouTube channel. Rapamycin, which for a long time has been the most promising molecule in our quest to prolong youth, was not making him younger; instead, it was "accelerating" his ageing.
Johnson, who is 47 and looks 46, conducts various experiments on himself in his effort to live like a young man for a very long time. I am counting on him. His food consumption is so calibrated that he knows the number of calories he has gulped. He does not eat after 11 am, unless he has to meet people socially and must eat at ungodly hours like 7 pm just to shut them up. He sleeps around 8:30 pm, alone. I know he has high standards for himself because he recently visited Delhi, probably out of ignorance, and refused to breathe the air for too long. Among the most important things he was performing on himself was taking small quantities of rapamycin, a drug that is chiefly used to prevent the body's rejection of organ transplants. It does not have approval as an anti-ageing drug, though it is widely believed to have potential for that. The compound had extended the lifespan of mice and worms beyond ambiguity, and of other animals, too. Johnson was its most famous human test subject.
このストーリーは、Mint Chennai の April 21, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Mint Chennai からのその他のストーリー
Mint Chennai
Inside Bengaluru's quiet recycling revolution
Stories from the alleys and gullies of India
4 mins
November 29, 2025
Mint Chennai
LIC’s response to voting on RIL, Adani resolutions
A Mint story on Friday reported how Life Insurance Corp. of India Ltd, or LIC, had approved or never opposed resolutions proposed before shareholders of Reliance Industries Ltd (RIL) or any Adani Group company since 1 April 2022, even as it rejected similar proposals at other large companies.
1 min
November 29, 2025
Mint Chennai
Tech focus drives Meesho's IPO prep
lier thismonth.
1 mins
November 29, 2025
Mint Chennai
Former DBS CEO is Temasek India's new non-exec chair
Piyush Gupta, the former chief executive of DBS Group, has joined Singaporean state-owned multinational investment firm Temasek as India chairman, albeit in a non-exec role, and will work with Ravi Lambah, head of India and strategic initiatives, the firm said. He will join on 1 December.
1 mins
November 29, 2025
Mint Chennai
Apple's 5th India store to open in Noida soon
Apple announced on Friday it will open its fifth retail store in India on 1 December in Noida's DLF Mall of India—marking its second store in the National Capital Region after Delhi, which opened in April 2023.
1 min
November 29, 2025
Mint Chennai
The ghosts that the wind and wildlife mimic
I couldn't be someone knocking on my door, could it?
5 mins
November 29, 2025
Mint Chennai
Everything that’s wrong with India’s development story
This new book inquires into the conditions under which India has tried to develop in the past 75-plus years
4 mins
November 29, 2025
Mint Chennai
Recreating Dharmendra's timeless style
The late movie superstar was the definition of what it means to have a strong personal style
1 min
November 29, 2025
Mint Chennai
Unfussy local bars make a comeback
Neighbourhood spots with affordable pricing and good food are back in the spotlight
3 mins
November 29, 2025
Mint Chennai
Women as custodians of Monpa heritage
The Monpa community in western Arunachal Pradesh is reviving its craft traditions and ploughing the surplus income into wildlife, habitat and heritage conservation
6 mins
November 29, 2025
Listen
Translate
Change font size

